CNTNAP2 and Cognitive impairment: CASPR2 was implicated in the trafficking of AMPA receptors to the synaptic membrane60,61, suggesting that glutamatergic transmission dysfunction could underpin the cognitive impairment seen in CASPR2-mediated CNS disease.